Exercise capacity and mortality in hypertensive men with and without additional risk factors

Hypertension

Volumn 53, Issue 3, 2009, Pages 494-499

  Kokkinos, Peter ^a,b   Manolis, Athanasios ^a,c   Pittaras, Andreas ^a   Doumas, Michael ^a   Giannelou, Angeliki ^a   Panagiotakos, Demosthenes B ^a,d   Faselis, Charles ^a   Narayan, Puneet ^a   Singh, Steven ^a,b   Myers, Jonathan ^e,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c IASO GENERAL HOSPITAL   (Greece)

^d HAROKOPIO UNIVERSITY   (Greece)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Cardiovascular risk factors; Exercise capacity; Hypertension; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXERCISE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; ENDURANCE; EXERCISE TOLERANCE; FITNESS; FOLLOW UP; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PUBLIC HOSPITAL; UNITED STATES;

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALIFORNIA; CARDIOVASCULAR DISEASES; DISTRICT OF COLUMBIA; EXERCISE TOLERANCE; FOLLOW-UP STUDIES; HOSPITALS, VETERANS; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PHYSICAL FITNESS; RISK FACTORS;

EID: 61749103521     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.127027     Document Type: Article

References (33)

1. MacMahon S, Petro R, Culler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler S. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
2. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. Hypertension. 2003;42:1206-1252.
4. World Health Organization. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002:57.
5. Grimm RH Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997;157:638-648.
6. Kokkinos PF, Narayan P, Papademetriou V. Exercise as hypertension therapy. Cardiol Clin. 2001;19:507-516.
7. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension. 2005;46:667-675.
8. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
9. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
10. Blair SN, Kohl HW, Barlow CE, Gibbons LW. Physical fitness and all-cause mortality in hypertensive men. Ann Med, 1991;23:307-312.
11. Pardaens K, Reybrouck T, Thijs L, Fagard R. Prognostic significance of peak oxygen uptake in hypertension. Med Sci Sports Exerc. 1996;28:794-800.
12. Kizer KW, Demakis JG, Feussner JR. Reinventing VA health care: systematizing quality improvement and quality innovation. Med Care. 2000;38(suppl I):I7-I16.
13. Selim AJ, Berlowitz DR, Fincke G, Rosen AK, Ren XS, Christiansen CL, Cong Z, Lee A, Kazis L. Risk-adjusted mortality rates as a potential outcome indicator for outpatient quality assessments. Med Care. 2002; 40:237-245.
14. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106:1883-1892.
15. Dresing TJ, Blackstone EH, Pashkow FJ, Snader CE, Marwick TH, Lauer MS. Usefulness of impaired chronotropic response to exercise as a predictor of mortality, independent of the severity of coronary artery disease. Am J Cardiol. 2000;86:602-609.
16. Wilkoff BL, Miller RE. Exercise testing for chronotropic assessment. Cardiol Clin. 1992;10:705-717.
17. Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol. 1990;131:160-168.
18. Myers J, Buchanan N, Walsh D, Kraemer M, McAuley P, Hamilton-Wessler M, Froelicher VF. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol. 1991;17:1334-1342.
19. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000.
20. Foster C, Jackson AS, Pollock ML, Taylor MM, Hare J, Sennett SM, Rod JL, Sarwar M, Schmidt DH. Generalized equations for predicting functional capacity from treadmill performance. Am Heart J. 1984;107: 1229-1234.
21. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol. 1993;22:175-182.
22. Blair SN, Kampert JB, Kohl HW III, Barlow CE, Macera CA, Paffenbarger RS Jr, Gibbons LW. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276:205-210.
23. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989;262:2395-2401.
24. Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290:1600-1607.
25. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med. 1993;328:533-537.
26. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, Al-Hani AJ, Black HR. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003;108:1554-1559.
27. Kokkinos PF, Myers J, Kokkinos JP, Pittaras A, Narayan P, Manolis A, Karasik P, Greenberg M, Papademetriou V, Singh S. Exercise capacity and mortality in black and white men. Circulation. 2008;117:614-622.
28. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A. Physical activity and public health. Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Spans Exerc. 2007;39:1423-1434.
29. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402-407.
30. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39:1435-1445.
31. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869-874.
32. Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet. 2008;371:2219-2221.
33. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461-1464.